Loading Events

Webinar #98 – Dreem EEG Headband to Assess Sleep EEG Biomarkers in SYNGAP1

  • This event has passed.

February 6, 2025 @ 3:00 pm – 4:00 pm America/New York

Jay Pathmanathan, MD, PhD
February 6, 2025

Dreem EEG Headband to assess Sleep EEG Biomarkers in SYNGAP1

We will be hearing from the Medical Director of Beacon Biosignals, Jay Pathmanathan, MD PhD, in a talk titled Dreem EEG Headband to Assess Sleep EEG Biomarkers in SYNGAP1. We are so pleased to have Jay Pathmanathan describe an upcoming trial run by Beacon Biosignals (which many have heard at our annual conference in December 2024).

Jay Pathmanathan, MD, PhD is an expert in all the aspects of creating a better way to measure and use EEG data.

We don’t have time to list all his achievements and qualifications, but I’ll highlight a few diverse skill sets that have convinced me he is the perfect person to solve the problem of measuring what is going on in brains in a non-invasive, low-barrier way while people are at home with their caregivers.

We can start with his Clinical Expertise:

  • He is Board certified in Neurology, Epilepsy, and Intraoperative Monitoring
  • Medical Director of EEG Laboratories and ICU Monitoring at U Penn
  • Besides being an expert clinical neurophysiologist, he has extensive knowledge of instrumentation and electrodiagnostic skills.
  • He is an Engineer, which is needed to build a new reliable device.

His education is so extensive as to be a teacher: we can add

  • Supervisor and mentor to 8 post-graduate physician trainees and instructors per year
  • Training and supervision of over 40 EEG Technologists

We need to include his successes in Application Development

  • Developed and maintain the clinical tools for EEG interpretation, management, and billing in use at the University of Pennsylvania to manage over 8000 studies per year and achieve a 30% increase in operations

And of course he also has experience in running Clinical Trials

  • He has been on multiple studies As a -PI, Co-PI, sub-I .
  • Experience in protocol development and FDA communications

Jay is the person we need, to create a clinical measure for SYNGAP1-related disorders, that can be used in clinical trials to measure changes in brain activity in people getting treatments.

« All Events